Guinea-Bissau vs Togo: Meningococcal A conjugate (MENGA) vaccine immunization coverage (%)
Guinea-Bissau
65.0%
in 2025
Togo
58.0%
in 2025
Guinea-Bissau rank
8th
Togo rank
10th
Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) over time
- Guinea-Bissau
- Togo
How they compare
Guinea-Bissau currently reports 65.0% against 58.0% in Togo, a difference of 7.0%.
That makes Guinea-Bissau's figure about 1.1 times Togo's.
The two have swapped places 1 time across 10 shared years of data; in 2016 it was Togo ahead.
Guinea-Bissau ranks 8th and Togo ranks 10th of 26 countries.
Togo has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 0.0% | 0.0% | — |
| 2020s | 28.3% | 37.7% | 9.3% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher meningococcal a conjugate (menga) vaccine immunization coverage (%), Guinea-Bissau or Togo?
- Guinea-Bissau, at 65.0% against 58.0% in Togo as of 2025.
- What is the difference in meningococcal a conjugate (menga) vaccine immunization coverage (%) between Guinea-Bissau and Togo?
- 7.0%, with Guinea-Bissau ahead.
- How many years of comparable data are there for Guinea-Bissau and Togo?
- 10 years are reported by both, from 2016 to 2025.
- How do Guinea-Bissau and Togo rank globally for meningococcal a conjugate (menga) vaccine immunization coverage (%)?
- Guinea-Bissau ranks 8th and Togo ranks 10th of 26 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.